Labcorp Holdings (NYSE:LH) has received the first FDA clearance for a rapid fentanyl urine test for use in emergency and clinical settings. The test is designed to give healthcare teams quick, ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the Labcorp Fentanyl Urine Visual Test, the first U.S. Food and Drug ...

The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...

After hanging out the for sale sign and filing for bankruptcy earlier this year, the genetic testing provider Invitae has found a new home for its portfolio at Labcorp. The two companies announced ...

While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the ...

The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs along with other hospital-based testing services. Like its chief ...

While the spinoff deal is positive for Labcorp, investors used the opportunity to sell on the news. Labcorp will do a $1 billion stock repurchase program and pay down debt. The company's revenues have ...

Shares of Labcorp Holdings Inc. LH rose 1.62% to $270.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.20% to 7,126.06 ...